Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 20344-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- LASS2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated LASS2 antibody (Cat. #20344-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Nogo-A reduces ceramide de novo biosynthesis to protect from heart failure.
LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion.
LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.
MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
Sasset L, Manzo OL, Zhang Y, Marino A, Rubinelli L, Riemma MA, Chalasani MLS, Dasoveanu DC, Roviezzo F, Jankauskas SS, Santulli G, Bucci MR, Lu TT, Di Lorenzo A
Cardiovascular research 2023 Mar 31;119(2):506-519
Cardiovascular research 2023 Mar 31;119(2):506-519
LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion.
Zhao WJ, Fan YP, Ou GY, Qiao XY
Journal of Cancer 2022;13(7):2281-2292
Journal of Cancer 2022;13(7):2281-2292
LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.
Huang L, Luan T, Chen Y, Bao X, Huang Y, Fu S, Wang H, Wang J
Journal of Cancer 2018;9(6):1017-1024
Journal of Cancer 2018;9(6):1017-1024
MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
Luan T, Fu S, Huang L, Zuo Y, Ding M, Li N, Chen J, Wang H, Wang J
Experimental cell research 2018 Dec 15;373(1-2):188-197
Experimental cell research 2018 Dec 15;373(1-2):188-197
miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
Wang H, Zhang W, Zuo Y, Ding M, Ke C, Yan R, Zhan H, Liu J, Wang J
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Dec;36(12):9631-40
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Dec;36(12):9631-40
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 20344-1-AP( LASS2 Antibody) at dilution of 1:300
- Sample type
- cell line
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 20344-1-AP( LASS2 Antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The LASS2 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human LASS2. This antibody recognizes human antigen. The LASS2 antibody has been validated for the following applications: ELISA, IF, WB analysis.